51.83
-1.51
(-2.83%)
At close: April 9 at 7:10:27 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 11 | 10 |
| Avg. Estimate | 4.23B | 4.56B | 18.23B | 18.91B |
| Low Estimate | 4.13B | 4.5B | 17.35B | 18.02B |
| High Estimate | 4.32B | 4.62B | 20.4B | 21.1B |
| Year Ago Sales | 4.08B | 4.34B | 17.6B | 18.23B |
| Sales Growth (year/est) | 3.68% | 5.15% | 3.61% | 3.68% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0IFJ.L | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 4/8/2025 |
| Maintains | Morgan Stanley: Underweight to Underweight | 3/20/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 3/4/2025 |
| Maintains | Mizuho: Outperform to Outperform | 3/3/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/3/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |